XML 16 R5.htm IDEA: XBRL DOCUMENT v3.19.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 9,630 $ 9,325
Marketable securities 70,221 90,590
Accounts receivable 11,772 11,330
Inventories 4,258 4,770
Prepaid expenses and other current assets 6,556 8,836
Total current assets 102,437 124,851
Property and equipment, net 1,749 1,911
Operating lease right-of-use assets 5,802  
Goodwill 18,491 18,491
Intangible assets, net 1,428 1,629
Research and development tax credit receivable 7,591 7,272
Other non-current assets 36,124 36,146
Total assets 173,622 190,300
Current liabilities:    
Current portion of long-term debt 104 106
Current portion of long-term related party payable 9,391 9,439
Current portion of operating lease liability 982  
Accounts payable 4,150 3,503
Deferred revenue 115 114
Accrued expenses 14,689 21,695
Other current liabilities 1,927 3,526
Total current liabilities 31,358 38,383
Long-term debt, less current portion 117,178 115,734
Long-term related party payable, less current portion 18,202 19,401
Long-term operating lease liability 3,889  
Other non-current liabilities 12,577 14,002
Total liabilities 183,204 187,520
Shareholders’ (deficit) equity:    
Preferred shares, nominal value of $0.01 per share; 50,000 shares authorized; none issued or outstanding at March 31, 2019 and December 31, 2018, respectively 0 0
Ordinary shares, nominal value of $0.01 per share; 500,000 shares authorized; 42,762 issued and 37,355 outstanding at March 31, 2019 and 42,720 issued and 37,313 outstanding at December 31, 2018 427 427
Treasury shares, at cost, 5,407 shares held at March 31, 2019 and December 31, 2018, respectively (49,998) (49,998)
Additional paid-in capital 434,199 433,756
Accumulated deficit (371,007) (357,989)
Accumulated other comprehensive loss (23,203) (23,416)
Total shareholders’ (deficit) equity (9,582) 2,780
Total liabilities and shareholders’ (deficit) equity $ 173,622 $ 190,300